Lv2
140 积分 2025-04-16 加入
The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
1个月前
已完结
Evidence for ligand-dependent and independent equilibration of RAMP bound forms of CTR
4个月前
已关闭
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
6个月前
已完结
Amylin: Pharmacology, Physiology, and Clinical Potential
6个月前
已完结
Effects of antidiabetic and anti-obesity pharmacotherapy on skeletal muscle mass
6个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
6个月前
已完结
How GLP-1 went from being a hard-to-handle hormone to a blockbuster success
6个月前
已完结
Cubanes in Medicinal Chemistry
7个月前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
8个月前
已完结
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
8个月前
已完结
皖公网安备34019202002308
